Both in Pharmaceuticals
Kailera Therapeutics vs ANI Pharmaceuticals
Over the past year KLRA returned −9.8% and ANIP returned +3.0%; their daily moves had a correlation of 0.22.
KLRA −9.8% ANIP +3.0%Growth of $1, one year, split-adjusted
| Metric | KLRA | ANIP |
|---|---|---|
| Price | $12.58 | $72.28 |
| Market cap | $1.63B | $1.66B |
| Today | +3.54% | +2.28% |
| 1 month | +16.1% | −0.4% |
| 6 months | — | −14.6% |
| Year to date | — | −8.4% |
| 1 year | — | −20.2% |
| Revenue growth (YoY) | — | +25.9% |
| Gross margin | — | 62.4% |
| Net margin | — | 8.6% |
| P/E (TTM) | — | 16.7× |
| Price / sales | — | 1.7× |
| Net cash | $916.7M | -$234.7M |
| Dividend yield | — | — |
| Volatility (60d) | — | 26.9% |
| Short % of float | 9.1% | 18.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).